AI and Cancer Research ── Prostate ── 2026-11-20
Prostate cancer: treatment, trials and AI
- Abstract
The International Society of Urological Pathology (ISUP) grade upgrading from biopsy to radical prostatectomy (RP) occurs in approximately 30%-40% of prostate cancer patients and may compromise treatment planning. Although multiparametric MRI (mpMRI) improves lesion characterization, prostatitis-like signal changes can mimic clinically significant cancer and confound radiological interpretation; however, no predictive model has incorporated mpMRI-diagnosed prostatitis as a variable for ISUP upgrading. This single-center retrospective study enrolled 503 consecutive men who underwent "12+1"-core transperineal ultrasound-guided systematic biopsy supplemented by cognitive mpMRI-targeted cores followed by laparoscopic RP (from May 2021 to October 2024). Least absolute shrinkage and selection operator (LASSO) logistic regression with 10-fold cross-validation was used for feature selection, and six machine learning classifiers were trained and evaluated on an independent test set (7:3 split). ISUP upgrading occurred in 195 patients (38.8%), and mpMRI-diagnosed prostatitis was significantly more prevalent in upgraded cases (27.2% vs 11.4%, P < 0.001). The random forest model achieved the highest weighted composite score (area under the receiver operating characteristic curve [ROC-AUC]: 0.823; average precision: 0.799) and was selected as the final model. SHapley Additive exPlanations (SHAP) analysis ranked feature importance as: basal tumor location (mean |SHAP|: 0.145), Prostate Imaging Reporting and Data System (PI-RADS) ≥4 (mean |SHAP|: 0.121), percentage of positive cores (mean |SHAP|: 0.100), maximum tumor diameter (mean |SHAP|: 0.062), and mpMRI-diagnosed prostatitis (mean |SHAP|: 0.040). As one of the first models to incorporate mpMRI-diagnosed prostatitis, this SHAP-interpretable framework showed that such prostatitis adds predictive value beyond PI-RADS scoring. This may help identify patients at heightened risk of undergrading on biopsy.
Journal IF-equivalent: 2.8 (OpenAlex 2-year mean citedness, value as of 2026-10-21, retrieved 2026-10-22; not the official Clarivate IF)Reference: Wang SY, Jin LC, Tian Z, Jia ZM, Li GZ, Chen X, et al. Predicting ISUP upgrading from biopsy to radical prostatectomy using an interpretable machine learning model with mpMRI-diagnosed prostatitis: a retrospective study. Asian J Androl. 2026 Nov 17 [Epub ahead of print]. doi:10.4103/aja202643. PMID: 43042515.Checked: Abstract only